|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001562,
umls-concept:C0007138,
umls-concept:C0030705,
umls-concept:C0068314,
umls-concept:C0101466,
umls-concept:C0205124,
umls-concept:C0205265,
umls-concept:C0205269,
umls-concept:C0684224,
umls-concept:C0699885,
umls-concept:C1555582
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-4-18
|
|
pubmed:abstractText |
This study was designed to assess the pharmacokinetics, safety, and antitumor activity of intravesically administered AD 32, a novel anthracycline, in patients with transitional cell carcinoma (TCC) of the bladder.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0090-4295
|
|
pubmed:author |
pubmed-author:BahnsonR RRR,
pubmed-author:BambergerM HMH,
pubmed-author:BellinghamCC,
pubmed-author:ChildsS JSJ,
pubmed-author:EdsonMM,
pubmed-author:GiantonioBB,
pubmed-author:GreenbergR ERE,
pubmed-author:IsraelMM,
pubmed-author:O'DwyerP JPJ,
pubmed-author:SteinbergG DGD,
pubmed-author:SweatmanTT,
pubmed-author:WoodDD
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
471-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9123721-Administration, Intravesical,
pubmed-meshheading:9123721-Aged,
pubmed-meshheading:9123721-Aged, 80 and over,
pubmed-meshheading:9123721-Anthracyclines,
pubmed-meshheading:9123721-Carcinoma, Transitional Cell,
pubmed-meshheading:9123721-Doxorubicin,
pubmed-meshheading:9123721-Female,
pubmed-meshheading:9123721-Humans,
pubmed-meshheading:9123721-Male,
pubmed-meshheading:9123721-Middle Aged,
pubmed-meshheading:9123721-Urinary Bladder Neoplasms
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Initial report on intravesical administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladder.
|
|
pubmed:affiliation |
Department of Surgery, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
